Filter by: Subject

Results Per Page:

Filter by: Subject

Bacteria (1)
Biologival evaluation (1)
Bisphosphonates (1)
Black South-African (BSAs) (1)
Bone metastases (1)
Bone scan (1)
Breast cancer (2)
Cancer (2)
Candida (1)
Cathelicidin (1)
Cathelicidin-derived peptide (CDP1) (1)
CDP1 (1)
Colloid-labeled-leukocytes (1)
Colorectal cancer (1)
Computerized tomography (CT) (2)
Computerized tomography' (CT) (1)
Developing countries (1)
Diagnosis (2)
DOTA (1)
Drugs (1)
Escherichia coli (1)
FDG PET (1)
FDG PET/CT (1)
Fludeoxyglucose (FDG) (1)
Fluorine-18-Fluorodeoxyglucose (FDG) (1)
Fungal infections (1)
Highly active antiretroviral therapy (HAART) (1)
HIV/AIDS (2)
Immunohistochemistry (IHC) (1)
In-vitro (1)
Increased bone turnover (1)
Infection (2)
Infection imaging (1)
Inflamation (1)
Inflammatory-bowel-disease (1)
Invasive fungal infection (IFI) (1)
Lipodystrophy (1)
LL37 (1)
Lung lesions (1)
Lymphomas -- Treatment (1)
Medicine (1)
Mycobacterium tuberculosis (MTB) (1)
NODAGA (2)
Non-prostate carcinoma (1)
Nuclear medicine (1)
Nuclear medicine imaging (1)
Oncology (1)
Ovarian cancer (1)
PET/CT (4)
Positron emission tomography (PET) (16)
Primary prostate carcinoma (PPC) (1)
Prostate carcinoma (2)
Prostate-specific membrane antigen (PSMA) (3)
Protein (1)
Racial differences (1)
Radiotracers (1)
Scintigraphy (1)
Serum tumor markers (1)
Single-photon emission computed tomography (SPECT) (1)
Single-photon emission computer tomography/computer tomography (SPECT/CT) (1)
Solid-phase peptide synthesis (1)
Staphylococcus-aureus infection (1)
Therapy (1)
Therapy monitoring (1)
Tomography, Emission (1)
Treatment monitoring (1)
Tuberculosis (TB) (2)
Tuberculosis -- Treatment -- South Africa (1)
Tumor recurrence (1)
UBI29-41 (1)
Ubiquicidin (1)
White cell scintigraphy (1)
White South-African (WSAs) (1)